By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

FDAAdvisoryCommittee.com 



     
Phone: Fax:


SEARCH JOBS








Company News
FDAAdvisoryCommittee.com Grants Orphan Drug Status to Eisai Inc. (ESALF.PK)'s Lenvatinib 2/14/2013 8:56:14 AM
FDAAdvisoryCommittee.com Rejects United Therapeutics Corporation (UTHR) Lung Drug 10/24/2012 7:48:35 AM
FDAAdvisoryCommittee.com : Salix Pharmaceuticals, Ltd. (SLXP) Supports Proposed Clinical Trial Design to Evaluate Repeat Treatment Cycles of XIFAXAN® for Irritable Bowel Syndrome with Diarrhea 11/17/2011 6:21:16 AM
FDAAdvisoryCommittee.com Grants Fluke Biomedical 510(k) Clearance for New ProSim(TM) Vital Signs Simulators 9/9/2011 7:14:59 AM
FDAAdvisoryCommittee.com to Webcast via TalkPoint the FDA Review of Bayer Corporation (BAY) and Johnson & Johnson (JNJ) Anti-Clot Drug Rivaroxaban on March 19th 3/11/2009 11:49:55 AM
FDA Advisory Committee Unanimously Recommends Accelerated Approval of ISENTRESS(TM) (raltegravir), Merck & Co., Inc. (MRK)'s Investigational Oral Integrase Inhibitor, for Treatment of HIV 9/5/2007 2:53:45 PM
Columbia Laboratories, Inc. (CBRX) Comments On FDA Reproductive Drugs Advisory Committee Recommendation On 17-OHPC; PROCHIEVE 8% Currently In Phase III Clinical Trial For Prevention Of Recurrent Preterm Birth 8/30/2006 12:17:20 PM
Live Webcast Of FDA Breast Implant Advisory Panel Meeting Available From FDAAdvisoryCommittee.com10/19/2005 5:13:16 PM
FDAAdvisoryCommittee.com To Webcast Dec. 2 Review Of Procter & Gamble's (PG) Sexual Dysfunction Drug Intrinsa; February Vioxx Meeting Also To Be Webcast Live10/19/2005 5:12:21 PM
ILEX Oncology, Inc. (ILXO) Release: FDA Advisory Committee Recommends Accelerated Clofarabine Approval For Most Common Pediatric Leukemia10/19/2005 5:12:20 PM
12
//-->